We are live on ! Find out more
NSCM

New South Capital Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 33.67%
This Fund
S&P 500
This Quarter Est. Return
+1.27%
1 Year Est. Return
+33.67%
3 Year Est. Return
+86.94%
5 Year Est. Return
+94.33%
10 Year Est. Return
+356.2%
AUM
$2.37B
AUM Growth
-$71.6M
Cap. Flow
-$62.9M
Cap. Flow %
-2.65%
Top 10 Hldgs %
49.35%
Holding
65
New
3
Increased
7
Reduced
47
Closed
–

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$57.7M
2
RPRX icon
Royalty Pharma
RPRX
+$13M
3
IWR icon
iShares Russell Mid-Cap ETF
IWR
+$9.34M
4
PLYA
Playa Hotels & Resorts
PLYA
+$8.51M
5
CCSI icon
Consensus Cloud Solutions
CCSI
+$4.15M

Top Sells

Rank Stock Value
1
VRT icon
Vertiv
VRT
+$57.5M
2
LKQ icon
LKQ Corp
LKQ
+$12.4M
3
FMC icon
FMC
FMC
+$9.83M
4
ZBRA icon
Zebra Technologies
ZBRA
+$7.79M
5
AZO icon
AutoZone
AZO
+$6.86M

Sector Composition

Rank Sector Weight
1 Technology 28.05%
2 Industrials 24.92%
3 Consumer Discretionary 17.76%
4 Financials 10.26%
5 Healthcare 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRT icon
1
Vertiv
VRT
$93B
$236M 9.94%
2,075,749
-484,437
-19% -$57.5M
AZO icon
2
AutoZone
AZO
$49.2B
$169M 7.13%
52,823
-2,168
-4% -$6.86M
ZBRA icon
3
Zebra Technologies
ZBRA
$14B
$169M 7.11%
437,020
-20,106
-4% -$7.79M
WCC
4
WESCO International
WCC
$16.7B
$126M 5.3%
695,598
-16,019
-2% -$3.03M
FISV
5
Fiserv Inc
FISV
$28.8B
$116M 4.91%
566,754
-30,572
-5% -$6.24M
TMO icon
6
Thermo Fisher Scientific
TMO
$213B
$81.2M 3.42%
156,054
+209
+0.1% +$115K
RPRX icon
7
Royalty Pharma
RPRX
$25.9B
$75.4M 3.18%
2,957,125
+490,754
+20% +$13M
OTEX icon
8
Open Text
OTEX
$6.15B
$69.2M 2.91%
2,442,450
-100,634
-4% -$3.1M
GIB icon
9
CGI
GIB
$15.1B
$66.5M 2.8%
608,631
-10,285
-2% -$1.16M
EEFT icon
10
Euronet Worldwide
EEFT
$2.72B
$62.9M 2.65%
611,543
-4,604
-0.7% -$469K
BN icon
11
Brookfield
BN
$104B
$60.1M 2.53%
1,567,997
-42,228
-3% -$1.59M
HBI
12
DELISTED
Hanesbrands
HBI
$58.1M 2.45%
7,133,547
-289,207
-4% -$2.28M
KMPR icon
13
Kemper
KMPR
$1.67B
$57.5M 2.42%
866,195
-27,781
-3% -$1.83M
NICE icon
14
Nice
NICE
$5.79B
$55M 2.32%
+323,718
New +$57.7M
SSNC icon
15
SS&C Technologies
SSNC
$18.1B
$52.9M 2.23%
698,608
-11,651
-2% -$872K
MSM icon
16
MSC Industrial Direct
MSM
$6.89B
$52M 2.19%
695,573
-19,508
-3% -$1.61M
ENS icon
17
EnerSys
ENS
$6.78B
$49.4M 2.08%
534,307
-18,745
-3% -$1.82M
OSW icon
18
OneSpaWorld
OSW
$2.61B
$48.6M 2.05%
2,440,778
-150,925
-6% -$2.8M
FDX icon
19
FedEx
FDX
$72.7B
$48.3M 2.03%
171,538
-2,158
-1% -$602K
DBRG icon
20
DigitalBridge
DBRG
$2.93B
$45.7M 1.93%
4,055,232
+115,029
+3% +$1.55M
HHH icon
21
Howard Hughes
HHH
$3.81B
$45M 1.9%
585,223
-16,946
-3% -$1.35M
ESI icon
22
Element Solutions
ESI
$8.95B
$45M 1.9%
1,770,013
-62,761
-3% -$1.7M
THS
23
DELISTED
Treehouse Foods
THS
$44.2M 1.86%
1,258,817
-105,413
-8% -$3.84M
LKQ icon
24
LKQ Corp
LKQ
$5.68B
$43.6M 1.84%
1,186,785
-324,610
-21% -$12.4M
WBD icon
25
Warner Bros
WBD
$65.9B
$36.2M 1.53%
3,428,889
-207,927
-6% -$1.93M
1
2 3

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

New South Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, New South Capital Management held 65 positions worth $2.37B, down 2.9% from $2.45B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.6%. New South Capital Management opened 3 new positions and made no exits, leaving the 65-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • New South Capital Management's largest Q4 2024 buy was Nice: 323,718 shares worth $55M.
  • New South Capital Management added most to Royalty Pharma in Q4 2024, an estimated $13M increase.
  • New South Capital Management's biggest Q4 2024 reduction was Vertiv, cutting an estimated $57.5M.
  • New South Capital Management's ten largest holdings make up 49% of its $2.37B portfolio in Q4 2024.
  • New South Capital Management opened 3 new positions and closed 0 in Q4 2024.
  • New South Capital Management's portfolio value fell 2.9% quarter-over-quarter to $2.37B.

Based on New South Capital Management's 13F filing for Q4 2024, filed 6 Feb 2025.